PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28130133-1	2017	In present investigation, doxorubicin (Dox) and soluble curcumin (Cur-2-HP-beta-CD-complex) combination was simultaneously loaded in inhalable bioresponsive chitosan microspheres (Dox/Cur-2-HP-beta-CD-complex-elastin-CMs) bearing a substrate-stimuli, elastin.	Doxorubicin	26-37	elastin	Homo sapiens	209-216	
28130133-1	2017	In present investigation, doxorubicin (Dox) and soluble curcumin (Cur-2-HP-beta-CD-complex) combination was simultaneously loaded in inhalable bioresponsive chitosan microspheres (Dox/Cur-2-HP-beta-CD-complex-elastin-CMs) bearing a substrate-stimuli, elastin.	Doxorubicin	26-37	elastin	Homo sapiens	251-258	
28130133-6	2017	Consistently, inhalable bioresponsive microspheres exhibited outstandingly lower IC50 of 3.4-muM in comparison to 6.5-muM of inhalable drug loaded microspheres (Dox/Cur-2-HP-beta-CD-complex-CMs) bearing no elastin, against A549, non-small cell lung cancer cells.	Doxorubicin	161-164	elastin	Homo sapiens	206-213	
28130133-9	2017	In conclusion, Dox/Cur-2-HP-beta-CD-complex-elastin-CMs warrant further in-vivo tumor regression study to prove its therapeutic efficacy.	Doxorubicin	15-18	elastin	Homo sapiens	44-51